# EDGAR Filing Document

**Accession Number:** 0001952674
**File Stem:** 0000899243-23-001104
**Filing Date:** 2023-1
**Character Count:** 9570
**Document Hash:** ac434d7d452f12b29a0d6bf5646f50f0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899243-23-001104.hdr.sgml**: 20230105

**ACCESSION NUMBER**: 0000899243-23-001104

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230104

**FILED AS OF DATE**: 20230105

**DATE AS OF CHANGE**: 20230105

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Westrick Thomas J.
- **CENTRAL INDEX KEY:** 0001952674

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41528
- **FILM NUMBER:** 23513364

**MAIL ADDRESS:**
- **STREET 1:** 500 W. MONROE STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60661
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GE HealthCare Technologies Inc.
- **CENTRAL INDEX KEY:** 0001932393
- **STANDARD INDUSTRIAL CLASSIFICATION:** X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
- **IRS NUMBER:** 882515116
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 500 WEST MONROE STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60661
- **BUSINESS PHONE:** 203-360-4369

**MAIL ADDRESS:**
- **STREET 1:** 500 WEST MONROE STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60661

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GE Healthcare Holding LLC
- **DATE OF NAME CHANGE:** 20220603

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Westrick Thomas J.<br><sub>(Last) (First) (Middle)</sub><br>500 W. MONROE STREET<br><sub>(Street)</sub><br>CHICAGO, IL 60661<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-04 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CEO, Patient Care Solutions_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GE HealthCare Technologies Inc. [ GEHC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) | $129.52 | 2023-01-04 |  | A |  | 9733 |  | <sup>(1)</sup> | 2023-09-13 | Common stock, par value $0.01 per share | 9733 | <sup>(1)</sup> | 9733 | D |  |
| Employee Stock Option (right to buy) | $142.15 | 2023-01-04 |  | A |  | 13773 |  | <sup>(1)</sup> | 2024-09-05 | Common stock, par value $0.01 per share | 13773 | <sup>(1)</sup> | 13773 | D |  |
| Employee Stock Option (right to buy) | $135.92 | 2023-01-04 |  | A |  | 13773 |  | <sup>(1)</sup> | 2025-09-11 | Common stock, par value $0.01 per share | 13773 | <sup>(1)</sup> | 13773 | D |  |
| Employee Stock Option (right to buy) | $161.30 | 2023-01-04 |  | A |  | 7804 |  | <sup>(1)</sup> | 2026-09-30 | Common stock, par value $0.01 per share | 7804 | <sup>(1)</sup> | 7804 | D |  |
| Employee Stock Option (right to buy) | $99.21 | 2023-01-04 |  | A |  | 17446 |  | <sup>(1)</sup> | 2027-11-17 | Common stock, par value $0.01 per share | 17446 | <sup>(1)</sup> | 17446 | D |  |
| Employee Stock Option (right to buy) | $76.66 | 2023-01-04 |  | A |  | 9312 |  | <sup>(1)</sup> | 2028-03-19 | Common stock, par value $0.01 per share | 9312 | <sup>(1)</sup> | 9312 | D |  |
| Employee Stock Option (right to buy) | $40.40 | 2023-01-04 |  | A |  | 23725 |  | <sup>(1)</sup> | 2028-12-21 | Common stock, par value $0.01 per share | 23725 | <sup>(1)</sup> | 23725 | D |  |
| Employee Stock Option (right to buy) | $51.67 | 2023-01-04 |  | A |  | 3229 |  | <sup>(1)</sup> | 2029-04-11 | Common stock, par value $0.01 per share | 3229 | <sup>(1)</sup> | 3229 | D |  |
| Employee Stock Option (right to buy) | $63.51 | 2023-01-04 |  | A |  | 13465 |  | <sup>(2)</sup> | 2030-03-02 | Common stock, par value $0.01 per share | 13465 | <sup>(2)</sup> | 13465 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2023-01-04 |  | A |  | 1513 |  | <sup>(4)</sup> | <sup>(4)</sup> | Common stock, par value $0.01 per share | 1513 | <sup>(4)</sup> | 1513 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2023-01-04 |  | A |  | 5568 |  | <sup>(5)</sup> | <sup>(5)</sup> | Common stock, par value $0.01 per share | 5568 | <sup>(5)</sup> | 5568 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2023-01-04 |  | A |  | 5464 |  | <sup>(6)</sup> | <sup>(6)</sup> | Common stock, par value $0.01 per share | 5464 | <sup>(6)</sup> | 5464 | D |  |

---

### Footnotes:

(1) Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

(2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

(3) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

(4) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

(5) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

(6) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

**Signature:** /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact  
**Date:** 2023-01-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**